SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests

Article

Abstract: Severe acute respiratory coronavirus 2 (SARS-CoV-2) has spread globally since its emergence in 2019.

Palabras claves:

Autores:

Adams E.R., Clark D.J., Cuevas L.E., Davies B.M.O., Eckersley N.M., Giorgi E., Hughes G.L., Kay G.A., Kirwan D.E., Krishna S., Owen S.I., Patterson E.I., Planche T., Staines H.M., Stefanie K. Menzies, Williams C.T.

Fuentes:

scopus